Abstract
ObjectivesThis study aimed to evaluate the incidence of health insurance claims recording the cancer stage and TNM codes representing tumor extension size (T), lymph node metastasis (N), and distant metastasis (M) for patients diagnosed with cancer and to determine whether this extracted data could be applied to the new ICD-11 codes.DesignA cross-sectional study design was used, with the units of analysis as individual outpatients. Two dependent variables were extraction feasibility of cancer stage and TNM metastasis information from each claim. Expressibility of the two variables in ICD-11 was descriptively analysed.Setting and participantsThe study was conducted in South Korea and study participants were outpatients: lung cancer (LC) (46616), stomach cancer (SC) (50103) and colorectal cancer (CC) (54707). The data set consisted of the first health insurance claim of each patient visiting a hospital from 1 July to 31 December 2021.ResultsThe absolute extraction success rates for cancer stage based on claims with cancer stage was 33.3%. The rates for stage for LC, SC and CC were 30.1%, 35.5% and 34.0%, respectively. The rate for TNM was 11.0%. The relative extraction success rates for stage compared with that for CC (the reference group) were lower for patients with LC (adjusted OR (aOR), 0.803; 95% CI 0.782 to 0.825; p<0.0001) but higher for SC (aOR 1.073; 95% CI 1.046 to 1.101; p<0.0001). The rates of TNM compared that for CC were 40.7% lower for LC (aOR, 0.593; 95% CI 0.569 to 0.617; p<0.0001) and 43.0% lower for SC (aOR 0.570; 95% CI 0.548 to 0.593; p<0.0001). There were limits to expressibility in ICD-11 regarding the detailed cancer stage and TNM metastasis codes.ConclusionExtracting cancer stage and TNM codes from health insurance claims were feasible, but expressibility in ICD-11 codes was limited. WHO may need to create specific cancer stage and TNM extension codes for ICD-11 due to the absence of current rules in ICD-11.
Funder
The Health Insurance Review and Assessment Service
Reference35 articles.
1. World Health Organization . ICD-11 2022 release. 2022. Available: https://www.who.int/news/item/11-02-2022-icd-11-2022-release
2. Australian Institute of Health and Welfare . ICD-11 review Stakeholder consultation report 2019 cat. No HWI 31. Canberra: AIHW. n.d. Available: https://www.aihw.gov.au/getmedia/9ca5f240-ab0f-40ba-9ed7-15216de2cb88/aihw-HWI-31.pdf.aspx?inline=true
3. Diagnostic classification of irritability and Oppositionality in youth: a global field study comparing ICD-11 with ICD-10 and DSM-5;Evans;J Child Psychol Psychiatry,2021
4. Michael Frost . World Health Organization Collaborating Centre for the Family of International Classifications Australia. ICD-11 Stakeholder Update - January 2022. 2022.
5. Assessment of the ICD-11 dimensional trait model: an introduction to the special section;Bagby;Psychol Assess,2020